719 — Shandong Xinhua Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Market Cap
HK$4.87bn
Enterprise Value
HK$5.50bn
Revenue
CNY8.47bn

Annual balance sheet for Shandong Xinhua Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	723	596	1,011	782	1,137
Net Total Accounts Receivable
Net Total Receivables	607	920	1,032	1,017	1,172
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,687	2,754	3,457	3,314	3,727
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,539	3,766	4,000	4,061	4,296
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	7,093	7,332	8,265	8,286	9,020
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,381	2,502	3,158	2,486	2,796
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	3,869	3,864	4,139	3,733	4,028
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	3,224	3,468	4,126	4,553	4,992
Total Liabilities & Shareholders' Equity	7,093	7,332	8,265	8,286	9,020
Total Common Shares Outstanding